Edgewise Therapeutics Statistics
Total Valuation
EWTX has a market cap or net worth of $4.91 billion. The enterprise value is $3.17 billion.
| Market Cap | 4.91B |
| Enterprise Value | 3.17B |
Important Dates
The last earnings date was Wednesday, November 4, 2026, before market open.
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
EWTX has 109.48 million shares outstanding. The number of shares has increased by 16.12% in one year.
| Current Share Class | 108.60M |
| Shares Outstanding | 109.48M |
| Shares Change (YoY) | +16.12% |
| Shares Change (QoQ) | +12.26% |
| Owned by Insiders (%) | 0.19% |
| Owned by Institutions (%) | 75.56% |
| Float | 74.27M |
Valuation Ratios
The trailing PE ratio is 5.16.
| PE Ratio | 5.16 |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 123.11 |
| PB Ratio | 2.61 |
| P/TBV Ratio | 3.02 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 3.15 |
| EV / Sales | n/a |
| EV / EBITDA | 2.81 |
| EV / EBIT | 2.82 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.30, with a Debt / Equity ratio of 0.00.
| Current Ratio | 12.30 |
| Quick Ratio | 12.10 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.00 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 92.15% and return on invested capital (ROIC) is 64.23%.
| Return on Equity (ROE) | 92.15% |
| Return on Assets (ROA) | 59.76% |
| Return on Invested Capital (ROIC) | 64.23% |
| Return on Capital Employed (ROCE) | 69.07% |
| Weighted Average Cost of Capital (WACC) | 6.45% |
| Revenue Per Employee | n/a |
| Profits Per Employee | $7.95M |
| Employee Count | 127 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, EWTX has paid $155.33 million in taxes.
| Income Tax | 155.33M |
| Effective Tax Rate | 13.33% |
Stock Price Statistics
The stock price has increased by +154.58% in the last 52 weeks. The beta is 0.40, so EWTX's price volatility has been lower than the market average.
| Beta (5Y) | 0.40 |
| 52-Week Price Change | +154.58% |
| 50-Day Moving Average | 40.84 |
| 200-Day Moving Average | 36.55 |
| Relative Strength Index (RSI) | 66.09 |
| Average Volume (20 Days) | 1,561,312 |
Short Selling Information
The latest short interest is 11.75 million, so 10.73% of the outstanding shares have been sold short.
| Short Interest | 11.75M |
| Short Previous Month | 11.22M |
| Short % of Shares Out | 10.73% |
| Short % of Float | 15.82% |
| Short Ratio (days to cover) | 6.61 |
Income Statement
| Revenue | n/a |
| Gross Profit | 1.35B |
| Operating Income | 1.13B |
| Pretax Income | 1.16B |
| Net Income | 1.01B |
| EBITDA | 1.13B |
| EBIT | 1.13B |
| Earnings Per Share (EPS) | $8.68 |
Balance Sheet
The company has $1.74 billion in cash and $3.38 million in debt, with a net cash position of $1.74 billion or $15.90 per share.
| Cash & Cash Equivalents | 1.74B |
| Total Debt | 3.38M |
| Net Cash | 1.74B |
| Net Cash Per Share | $15.90 |
| Equity (Book Value) | 1.63B |
| Book Value Per Share | 14.92 |
| Working Capital | 1.63B |
Cash Flow
In the last 12 months, operating cash flow was -$201.90 million and capital expenditures -$382,000, giving a free cash flow of -$202.28 million.
| Operating Cash Flow | -201.90M |
| Capital Expenditures | -382,000 |
| Depreciation & Amortization | 2.13M |
| Net Borrowing | n/a |
| Free Cash Flow | -202.28M |
| FCF Per Share | -$1.85 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
EWTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -16.12% |
| Shareholder Yield | -16.12% |
| Earnings Yield | 19.37% |
| FCF Yield | -4.11% |
Analyst Forecast
The average price target for EWTX is $54.00, which is 20.43% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $54.00 |
| Price Target Difference | 20.43% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |